Marshall Wace, LLP Reviva Pharmaceuticals Holdings, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
39Shares Held
9.96MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$3.6 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.07 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.71 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.16 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$773,8290.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $23.1M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...